4 Results for "

hHDAC6

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "hHDAC6" in MCE Product Catalog:

  • Isoforms Recommended:
Referencia número: HY-162658
Target:  

HDAC Apoptosis

Áreas de investigación:  

Cancer

Leuxinostat is an inhibitor for HDAC with IC50 of 30 nM for hHDAC6. Leuxinostat inhibits the proliferation of cells THP1, K562, U937 and MEK1, induces apoptosis in leukemia cells NB4 and MOLT-4. Leuxinostat inhibits the expansion of hematopoietic stem cells and exhibits antileukemic activity in zebrafish models .
loading...
    loading...
Referencia número: HY-179227
Target:  

HDAC

Áreas de investigación:  

Neurological Disease

HDAC6 ligand-7 (Compound 16a) is a positron emission tomography (PET) tracer for the deacetylase 6 (HDAC6) enzyme with a Kd value of 1.66 nM. HDAC6 ligand-7 exhibits excellent HDAC6 inhibitory activity, with IC50 values of 2.7 and 3.7 nM for hHDAC6 and mHDAC6, respectively, and has high selectivity for HDAC1/4/7/8. HDAC6 ligand-7 after being radioactively labeled with fluorine-18, [¹F]HDAC6 ligand-7 shows varying degrees of radioactive uptake in PET, which can reflect the specific binding to HDAC6. HDAC6 ligand-7 can be used for the study of HDAC6 imaging .
loading...
    loading...
Referencia número: HY-124782
No. CAS: 1884231-52-0
Pureza:  ≥95.0%
Target:  

HDAC

Áreas de investigación:  

Infection

HDAC8-IN-8 (15a) is an HDAC8 inhibitor, with IC50 values of 23.9 μM and 268.2 μM for hHDAC8 and smHDAC8 respectively. And for hHDAC1 and hHDAC6, the IC50 values are 12.1 μM and 2.9 μM respectively. HDAC8-IN-8 can be used in schistosomiasis-related research .
loading...
    loading...
Referencia número: HY-184505
No. CAS: 2790482-16-3
Target:  

HDAC

Áreas de investigación:  

Cancer

(±)-trans-BAS-2 is a hHDAC6 inhibitor with an IC50 value of 0.462 μM. (±)-trans-BAS-2 serves as a scaffold for the design of proteolysis-targeting chimeras (PROTACs) and induces proteasome-dependent degradation of hHDAC6 in cells. (±)-trans-BAS-2 can be used in the research of triple-negative breast cancer and multiple myeloma .
loading...
    loading...